|
52756
|
Vitamine B2
Riboflavine
|
|
EDTA (diepgevroren) |
1x per week |
94 (3,9) |
–
|
73723-9
nmol/L FAD |
—
|
› |
|
52754
|
Vitamine B1
Thiamine pyrofosfaat
|
|
EDTA (diepgevroren) |
Dagelijks |
132 (5,5) |
B
|
74444-1
nmol/L ThPP |
—
|
› |
|
52752
|
Caroteen (beta-fractie)
|
|
Serum |
1x per week |
310 (12,9) |
–
|
2053-7
µg/dL |
14642-3
µmol/L |
› |
|
52750
|
Vitamine A
Retinol
|
|
Serum |
5x per week |
113 (4,7) |
B
|
2923-1
µg/dL |
14905-4
µmol/L |
› |
|
52670
|
Fosfatidylethanol (study)
PETH
|
|
EDTA |
1x per 2 weken |
133 (5,5) |
B
|
97607-6
ng/mL |
—
|
› |
|
52668
|
CDT (IFCC)
CDT (IFCC)
|
|
Serum |
2x per week |
192 (8) |
B
|
48495-6
% DST |
—
|
› |
|
52667
|
Fosfatidylethanol
|
|
EDTA |
3x per week, op Maandag, Woensdag en Vrijdag |
137 (5,7) |
B
|
74661-0
ng/mL |
—
|
› |
|
52646
|
Homocysteïne
|
|
Homocysteïne |
Dagelijks |
3 (0,1) |
–
|
13965-9
µmol/L |
—
|
› |
|
52214
|
Vetzurenprofiel
Panel
EFA, Vetzuren in plasma, Vetzuurprofiel
|
|
Serum, Heparine (Lithium-heparinebuis) |
|
315 (13,1) |
–
|
—
|
—
|
› |
|
52213
|
verhouding
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
282 (11,8) |
–
|
—
|
—
|
› |
|
52167
|
Magnesium (volbloed)
|
|
Oligo-elementen (spoorelementen) |
Dagelijks |
46 (1,9) |
–
|
21377-7
µg/l |
—
|
› |
|
52165
|
Magnesium in RBC
Panel
Magnesium intraerythrocytair
|
|
Oligo-elementen (spoorelementen) |
|
115 (4,8) |
–
|
2597-3
|
—
|
› |
|
52148
|
Calcium (volbloed)
|
|
Oligo-elementen (spoorelementen) |
Dagelijks |
108 (4,5) |
–
|
49765-1
µg/l |
—
|
› |
|
51691
|
Glutathion
|
|
Heparine (diepgevroren) |
1x per week |
165 (6,9) |
–
|
91685-8
mg/l |
57005-1
µmol/l |
› |
|
51685
|
Coenzyme Q10
Coenzyme Q10, Ubiquinone
|
|
Heparine (Lithium-heparinebuis) |
1x per week |
214 (8,9) |
–
|
27923-2
µg/L |
75050-5
nmol/L |
› |
|
44517
|
FibroMAX
Panel
ActiTest, AshTest, FibroTest
|
|
Serum, Glucose (Fluoridebuis) |
|
|
–
|
—
|
—
|
› |
|
44516
|
FIBROTEST
Panel
Actitest, FibroSure
|
|
Serum |
|
20 (0,8) |
–
|
—
|
—
|
› |
|
34413
|
Sex hormone bind. glob.
|
|
Serum |
Maandag t/m Zaterdag |
2 (0,1) |
B
|
13967-5
nmol/L |
—
|
› |
|
34390
|
Pre-eclampsie
Panel
|
|
Serum |
|
4 (0,2) |
–
|
—
|
—
|
› |
|
34388
|
sFlt-1 (3e trim.)
soluble FMS-like tyrosine kinase-1 (3de trimester)
|
|
Serum |
Dagelijks |
4 (0,2) |
B
|
74756-8
pg/ml |
—
|
› |
|
34387
|
PlGF (3e trim.)
Placental Growth Factor (3de trimester)
|
|
Serum |
Dagelijks |
4 (0,2) |
B
|
74755-0
pg/mL |
—
|
› |
|
34384
|
PlGF (1e trim.)*
Placental Growth Factor (1ste trimester)
|
|
Serum |
Dagelijks |
1 (0,1) |
B
|
—
pg/mL |
—
|
› |
|
34383
|
Risico pre-eclampsie EPE
|
|
Serum |
|
95 (4) |
–
|
—
|
—
|
› |
|
34375
|
Vrij testo.+SHBG-index(S)
Panel
BioT
|
|
Serum |
|
3 (0,1) |
–
|
14914-6
|
—
|
› |
|
34356
|
DHEA-sulfaat
DHEA-S, DHEA-sulfaat, DHEA-sulfate
|
|
Serum |
Maandag t/m Zaterdag |
2 (0,1) |
–
|
2191-5
µg/dL |
14688-6
µmol/L |
› |
|
34351
|
Androstaandiolglucuronide
3 alfa-diol glucuronide, 5 alfa-androstaan-3 alfa-17 beta-diol-glucuronide, 5 alfa-androstane-3 alfa-17 beta-diol-glucuronide
|
|
Serum |
2x per week |
89 (3,7) |
–
|
1680-8
ng/mL |
15008-6
nmol/L |
› |
|
34336
|
Testosteron
|
|
Serum |
Maandag t/m Zaterdag |
2 (0,1) |
B
|
2986-8
ng/dL |
14913-8
nmol/L |
› |
|
34300
|
Oestron
3-hydroxy-1,3,5(10)-estratien-17-one, E1, Estrone
|
|
Serum |
2x per week |
34 (1,4) |
–
|
2258-2
pg/mL |
22663-9
nmol/L |
› |
|
31208
|
Klin symp + HRG CYTO
Panel
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
275 (11,4) |
–
|
—
|
—
|
› |
|
31207
|
Klin symp + HRG HPV
Panel
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
360 (15) |
–
|
—
|
—
|
› |
|
31206
|
Opvolg diagn/therap CYTO
Panel
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
257 (10,7) |
–
|
—
|
—
|
› |
|
31205
|
Opvolg diagn/therap HPV
Panel
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
277 (11,6) |
–
|
—
|
—
|
› |
|
31203
|
Tweede triage (12 maand)
Panel
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
241 (10) |
–
|
—
|
—
|
› |
|
30207
|
Klin symp + HRG
Panel
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
292 (12,2) |
–
|
—
|
—
|
› |
|
30204
|
Cyto buiten RIZIV
Panel
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
208 (8,7) |
–
|
—
|
—
|
› |
|
30203
|
Preventief screen RIZIV
Panel
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
193 (8) |
–
|
—
|
—
|
› |
|
30146
|
hpv d2
Panel
|
|
|
|
381 (15,9) |
–
|
—
|
—
|
› |
|
30145
|
HPV d1
Panel
|
|
|
|
333 (13,9) |
–
|
—
|
—
|
› |
|
30144
|
cyto + HPV NL
Panel
Human Papillomavirus
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
328 (13,7) |
–
|
—
|
—
|
› |
|
30127
|
HPV+cyto buiten RIZIV
Panel
Cervixuitstrijkje (dunnelaag cytologie) - Buiten RIZIV, Human Papillomavirus, Papsmear (dunnelaag cytologie) - Buiten RIZIV
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
245 (10,2) |
–
|
—
|
—
|
› |
|
30126
|
Opvolging diagn/therap
Panel
Cervixuitstrijkje (dunnelaag cytologie) - Diagnostisch, Human Papillomavirus, Papsmear (dunnelaag cytologie) - Diagnostisch
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
260 (10,8) |
–
|
—
|
—
|
› |
|
30105
|
ppp vervolg 2
Panel
|
|
|
|
|
–
|
—
|
—
|
› |
|
30104
|
ppp vervolg
Panel
|
|
|
|
|
–
|
—
|
—
|
› |
|
30103
|
HPV + Cytologie
Panel
Cervixuitstrijkje (dunnelaag cytologie) - Preventief, Human Papillomavirus, Papsmear (dunnelaag cytologie) - Preventief
|
|
ThinPrep (Cervix- / Vloeistofcytologie) |
|
258 (10,7) |
–
|
—
|
—
|
› |
|
30100
|
HPV buiten RIZIV
Panel
Human Papillomavirus
|
|
|
|
166 (6,9) |
–
|
—
|
—
|
› |
|
30084
|
Differentiatie rondcellen
Panel
|
|
Sperma (Semen) |
|
192 (8) |
–
|
—
|
—
|
› |
|
30082
|
M.A.R. direct IgG
Directe Mixed Agglutination Reaction-test IgG
|
|
Sperma (Semen) |
Dagelijks |
46 (1,9) |
–
|
—
% |
—
|
› |
|
30081
|
M.A.R. (semenplasma)
|
|
Sperma (Semen) |
Maandelijks |
1.250 (52,1) |
–
|
—
% |
—
|
› |
|
30073
|
M.A.R. direct IgA
|
|
Sperma (Semen) |
|
45 (1,9) |
–
|
—
% |
—
|
› |
|
29780
|
hpvabb
Panel
Kwalitatieve Hoog-Risico Humaan Papillomavirus DNA L1
|
|
|
|
|
–
|
—
|
—
|
› |
